APA (7th ed.) Citation

H, J., J, H., H, K., HR, K., GY, K., KA, K., . . . SH, P. (2022). A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma. Frontiers in oncology, 12, 874385. https://doi.org/10.3389/fonc.2022.874385

Chicago Style (17th ed.) Citation

H, Jo, et al. "A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma." Frontiers in Oncology 12 (2022): 874385. https://doi.org/10.3389/fonc.2022.874385.

MLA (9th ed.) Citation

H, Jo, et al. "A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma." Frontiers in Oncology, vol. 12, 2022, p. 874385, https://doi.org/10.3389/fonc.2022.874385.